1 / 23

Updates on GLP-1 Receptor Agonists: Improving Adherence in Type 2 Diabetes

Updates on GLP-1 Receptor Agonists: Improving Adherence in Type 2 Diabetes. Goals. Clinical Efficacy: GLP-1 Receptor Agonists. Addressing Patient-Related Barriers to GLP-1 Agonist Use. Promoting Adherence to GLP-1 Receptor Agonist Therapy. The Importance of Patient Education.

jesus
Download Presentation

Updates on GLP-1 Receptor Agonists: Improving Adherence in Type 2 Diabetes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Updates on GLP-1 Receptor Agonists: Improving Adherence in Type 2 Diabetes

  2. Goals

  3. Clinical Efficacy: GLP-1 Receptor Agonists

  4. Addressing Patient-Related Barriers to GLP-1 Agonist Use

  5. Promoting Adherence to GLP-1 Receptor Agonist Therapy

  6. The Importance of Patient Education

  7. Partnering With the Patient

  8. Currently FDA-Approved GLP-1 Receptor Agonists

  9. Adherent Patients More Likely to Achieve Glycemic Control

  10. ADA/EASD 2012 Recommendations for Antihyperglycemic Therapy

  11. Pancreatic Safety of Incretin-based Drugs

  12. Talking to Your Patient: Pancreatitis

  13. Optimizing GLP-1 Receptor Agonists: Addressing Injection Phobia

  14. Fixed Ratio Combinations: Clinical Efficacy

  15. Key Takeaways

  16. Abbreviations

  17. References

  18. References (cont)

  19. References (cont)

  20. References (cont)

More Related